Price Fluctuation Risk of Securities Held
First written in FY2016. 8 of 32 entries say "Restated". Latest entry: 2026-08-14.
Bank of The Ryukyus,Limited moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.
The whole theme swung hardest in 2019: 70 of 144 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2026WorsenedAnnual report
「The valuation difference on other securities for the current consolidated fiscal year was negative ¥9,299 million.」
The valuation difference on other securities deteriorated from negative ¥7,605 million in the previous fiscal year to negative ¥9,299 million. It also disclosed a price fluctuation risk exposure of ¥8,676 million. - FY2026-H1MitigatedAnnual report
「Total 674,492 682,209 △7,717」
The valuation difference on other securities narrowed from negative ¥11,102 million at the end of the previous fiscal year to negative ¥7,717 million. No impairment losses were recognized during the current interim period. - FY2025-H1WorsenedAnnual report
「Total 649,471 653,511 △4,040」
The valuation difference on other securities widened from negative ¥1,904 million at the end of the previous fiscal year to negative ¥4,040 million at the end of the interim period. No impairment losses were recognized during the current interim consolidated accounting period. - FY2024WorsenedAnnual report
「Total 611,939 613,843 △1,904」
The valuation difference on other securities was negative ¥1,904 million, and the valuation loss widened from negative ¥1,727 million at the end of the previous fiscal year. Meanwhile, no impairment losses were recognized in the current fiscal year. - FY2024-Q3MitigatedAnnual report
「Total 600,665 599,542 △1,123 No impairment losses were recognized during the current third-quarter consolidated cumulative period.」
The valuation difference on other securities narrowed from negative ¥1,727 million at the end of the previous fiscal year to negative ¥1,123 million, and no impairment losses were recognized during the current third-quarter cumulative period. - FY2024-Q2WorsenedAnnual report
「Total 589,829 596,061 △6,231」
The valuation difference on other securities widened from negative ¥1,727 million at the end of the previous fiscal year to negative ¥6,231 million at the end of the interim period, increasing the valuation loss. Meanwhile, no impairment losses were recognized during the current interim consolidated accounting period. - FY2023-Q3RestatedAnnual report
「No impairment losses were recognized during the current third-quarter consolidated cumulative period.」
It reconfirmed that no impairment losses were recognized on securities held during the current third-quarter cumulative period. - FY2023-Q1No impairment losses in the first quarterAnnual report
「There were no impairment losses during the nine-month period of the current consolidated fiscal year.」
No impairment losses on securities held were recognized in the current first quarter, updating the situation from the ¥31 million in impairment losses on shares recognized in the previous fiscal year. - FY2022WorsenedAnnual report
「As of 31 March 2022, the Bank's total price fluctuation risk exposure (VaR), excluding trading-related risk, was ¥2,405 million.」
Price fluctuation risk exposure increased from ¥1,946 million in the previous fiscal year to ¥2,405 million, and ¥31 million in impairment losses on shares was also recognized in the current fiscal year. - FY2022-Q2MaterialisedAnnual report
「The amount of impairment losses recognized during the current interim consolidated accounting period was ¥31 million on shares.」
It recognized ¥31 million in impairment losses on shares held, resulting in a loss from price fluctuation risk during the interim period. - FY2022-Q1MaterialisedAnnual report
「The amount of impairment losses recognized during the current first-quarter consolidated cumulative period was ¥33 million on shares.」
Unlike the previous fiscal year, when no impairment losses were recognized, ¥33 million in impairment losses was recognized on shares held in the current first quarter. - FY2021MitigatedAnnual report
「No impairment losses were recognized during the consolidated fiscal year.」
No impairment losses on securities held were recognized in the current fiscal year, an improvement from the ¥259 million in impairment losses on shares recognized in the previous fiscal year. The price fluctuation risk exposure was ¥1,946 million. - FY2021-Q3RestatedAnnual report
「No impairment losses were recognized during the current third-quarter consolidated cumulative period.」
It reconfirmed that no impairment losses on securities held were recognized during the current third-quarter cumulative period. - FY2021-Q2RestatedAnnual report
「There was no impairment loss during the interim consolidated accounting period.」
It reconfirmed that no impairment losses were recognized on securities held during the current interim consolidated accounting period. - FY2021-Q1No impairment losses in the first quarterAnnual report
「There were no impairment losses during the nine-month period of the current consolidated fiscal year.」
No impairment losses on securities held were recognized in the current first quarter, updating the situation from the ¥259 million in impairment losses on shares recognized in the previous consolidated fiscal year. - FY2020-Q3MaterialisedAnnual report
「The amount of impairment losses recognized during the current third-quarter consolidated cumulative period was ¥68 million on shares.」
It disclosed that it had recognized ¥68 million in impairment losses on shares held, resulting in a loss from the price fluctuation risk of securities held. - FY2020-Q2MaterialisedAnnual report
「The amount of impairment losses recognized during the current interim consolidated accounting period was ¥78 million on shares.」
It recognized ¥78 million in impairment losses on shares held, resulting in a loss from the price fluctuation risk of securities held during the interim period. - FY2020-Q1MaterialisedAnnual report
「The amount of impairment losses recognized during the current first-quarter consolidated cumulative period was ¥68 million on shares.」
It recognized ¥68 million in impairment losses on shares held, resulting in a loss from the price fluctuation risk of securities held during the quarter. - FY2019MaterialisedAnnual report
「The amount of impairment losses recognized during the current consolidated fiscal year was ¥121 million on shares.」
It recognized ¥121 million in impairment losses on shares, resulting in a loss from the price fluctuation risk of securities held. The price fluctuation risk exposure (VaR) was ¥5,549 million. - FY2019-Q3MaterialisedAnnual report
「The amount of impairment losses recognized during the current third-quarter consolidated cumulative period was ¥72 million on shares.」
It recognized ¥72 million in impairment losses on shares held due to a decline in their market value, resulting in a loss from price fluctuation risk. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes or newly arising risks from those described in the annual securities report for the previous fiscal year regarding business and other risks that could materially affect investors' decisions.」
It stated that there had been no significant changes or new risks regarding the price fluctuation risk of securities held. - FY2018VaR updateAnnual report
「As of 31 March 2018, the Bank's total price fluctuation risk exposure (VaR), excluding trading-related risk, was ¥9,900 million.」
The price fluctuation risk exposure (VaR) was ¥9,900 million. It also disclosed a price fluctuation risk of ¥1,656 million based on TOPIX volatility. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes or newly arising risks from those described in the annual securities report for the previous fiscal year regarding business and other risks that could materially affect investors' decisions.」
It stated that there had been no significant changes or new risks regarding the price fluctuation risk of securities held. - FY2017WorsenedAnnual report
「As of 31 March 2017, the Bank's total price fluctuation risk exposure (VaR), excluding trading-related risk, was ¥10,140 million.」
It disclosed a price fluctuation risk exposure (VaR) of ¥10,140 million, up from ¥8,776 million reported in the previous annual disclosure. Meanwhile, it stated that the price fluctuation risk based on TOPIX volatility was ¥1,893 million. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes or newly arising risks from those described in the annual securities report for the previous fiscal year regarding business and other risks that could materially affect investors' decisions.」
It reconfirmed that there had been no significant changes or new risks regarding the price fluctuation risk of securities held. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes or newly arising risks from those described in the annual securities report for the previous fiscal year regarding business and other risks that could materially affect investors' decisions.」
It stated that there had been no significant changes or new risks regarding the price fluctuation risk of securities held. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes or newly arising risks from those described in the annual securities report for the previous fiscal year regarding business and other risks that could materially affect investors' decisions.」
It stated that there had been no significant changes or newly arising risks since the previous fiscal year regarding the price fluctuation risk of securities held. - FY2016First statedAnnual report
「However, fluctuations in interest rates, exchange rates and share prices may cause the value of financial assets held by the Bank Group to fluctuate, potentially adversely affecting its operating performance and financial condition.」
It disclosed a price fluctuation risk exposure (VaR) of ¥8,776 million and a price fluctuation risk of ¥2,355 million based on TOPIX volatility.